The PubMed entry describes a peer-reviewed research article titled “Archetype Analysis of Lung Adenocarcinoma Premalignancy Links Heterogeneity in Premalignant Lesions to Diverging Features of Invasive Disease.” The article appeared in Molecular Cancer Research on 2026 Sep 2 (24[9]:737–753) and, according to the title, addresses relationships between heterogeneity in premalignant lung lesions and subsequent features of invasive lung adenocarcinoma.
This citation includes standard bibliographic metadata: the journal Mol Cancer Res; publication date 2026 Sep 2; volume and page range 24(9):737–753; DOI 10.1158/1541-7786.MCR-25-1093; PubMed PMID 42089783; and PMCID PMC13455826. The PubMed entry links to a free full-text version available on PubMed Central.
The published author list includes Kelley E Anderson and multiple coauthors. Contributing authors are affiliated with the Section of Computational Biomedicine at Boston University Chobanian and Avedisian School of Medicine, the Department of Medicine and Department of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA, the Department of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, and related pathology departments at Boston University. The PubMed record provides the full author list and institutional affiliations in the citation header.
The PubMed entry provides a link to the full text hosted on PubMed Central (PMCID PMC13455826). Readers seeking complete experimental details, figures, methods, statistical analyses, and the investigators’ interpretations should consult the PMC full-text article for authoritative information.
By its wording, the study uses an archetype analysis framework to examine premalignant states in lung adenocarcinoma. The title indicates the authors investigated how heterogeneity among premalignant lesions may be associated with differing characteristics of later invasive disease. This suggests an interest in early lesion biology, heterogeneity mapping, and potential links to invasive tumor phenotypes, though the specifics of approach and findings are not provided in the excerpt.
The PubMed snippet supplied here contains the citation, author and affiliation lists, and links to the full text but does not include the article abstract, methods, results, figures, or conclusions. Therefore, the following items are not reported in this source excerpt and cannot be summarized here:
To avoid inventing or inferring data, these key scientific details must be obtained from the full-text article.
The PubMed record provides direct links to the publisher’s page and a free PMC copy (PMCID PMC13455826). Clinicians, researchers, and other readers should access the PMC full text to review the abstract, detailed methods, results, figures, tables, and the authors’ interpretation. Reviewing the complete article is necessary to:
This PubMed entry documents a 2026 Mol Cancer Res article that, by title, links premalignant lesion heterogeneity with diverging features of invasive lung adenocarcinoma. The citation supplies complete identifiers (PMID, PMCID, DOI) and author affiliations but does not include the abstract or substantive results within the provided excerpt. To accurately interpret clinical relevance or to extract methodological and result-level detail, consult the full-text article at the provided PMCID link.